000 | 01486 a2200361 4500 | ||
---|---|---|---|
005 | 20250513184735.0 | ||
264 | 0 | _c19990726 | |
008 | 199907s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMead, A N | |
245 | 0 | 0 |
_aCNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 1999 |
||
300 |
_a9-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology |
650 | 0 | 4 |
_aAmphetamine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCentral Nervous System Stimulants _xpharmacology |
650 | 0 | 4 |
_aConditioning, Operant _xdrug effects |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aQuinolones _xpharmacology |
650 | 0 | 4 |
_aQuinoxalines _xpharmacology |
650 | 0 | 4 |
_aReceptors, AMPA _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Glycine _xdrug effects |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
700 | 1 | _aStephens, D N | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 290 _gno. 1 _gp. 9-15 |
|
999 |
_c10340111 _d10340111 |